• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 1.17% Nasdaq Up 1.27%

    Epizyme, Inc. (EPZM)

    -NasdaqGS
    18.48 Apr 20, 4:00PM EDT
    Add to Portfolio
    Prev Close:18.48
    Open:N/A
    Bid:18.15 x 200
    Ask:18.99 x 300
    1y Target Est:38.50
    Beta:3.513
    Earnings Date:May 11 - May 15 (Est.)
    Day's Range:N/A - N/A
    52wk Range:16.51 - 40.98
    Volume:0
    Avg Vol (3m):393,679
    Market Cap:637.04M
    P/E (ttm):N/A
    EPS (ttm):-1.67
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for EPZM

    Comparison

    Symbol% ChgMkt Cap
    EPZM 0.00%637.04M
    GSK113.30B
    NVS245.24B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):15.38
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :-3.26
    Quarterly EPS Est (Mar-15) :-1.04
    Mean Recommendation*:1.9
    PEG Ratio (5 yr expected):N/A

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Epizyme, Inc., a clinical stage biopharmaceutical company, discovers and develops epigenetic therapies for cancer patients. Its proprietary product platform creates small molecule inhibitors of a 96-member class of enzymes known as histone methylt... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback